PatientsLikeMe ™
Join Now! (It’s free)
Already a member? Sign in
Filter by:
patients
See More Symptoms
See all 7092 symptoms in the PatientsLikeMe system shared by patients just like you.
Transplant rejection prevention Report
Immunosuppression reduces the activation or efficacy of the immune system. Deliberately induced immunosuppression is generally done to prevent the body from rejecting an organ transplant, treating graft-versus-host disease after a bone marrow transplant, or to treat auto-immune diseases.
What we've learned from patients who report Transplant rejection prevention
Symptom severities
|
Severe
|
2 |  |
|---|---|---|
|
Moderate
|
6 |  |
|
Mild
|
10 |  |
|
None
|
55 |  |
What patients report taking for the purpose of treating Transplant rejection prevention
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Prograf | 238 |  |
|
| Prednisone | 201 | |
|
| CellCept | 151 | |
|
| Tacrolimus | 150 | |
|
| Mycophenolate | 130 | |
|
| Myfortic | 60 | |
|
| Rapamune | 47 | |
|
| Cyclosporine | 39 | |
|
| Neoral | 36 | |
|
| Methylprednisolone | 19 | |
|
| Imuran | 19 | |
|
| Azathioprine | 19 | |
|
| Sirolimus | 17 | |
|
| Gengraf | 15 | |
|
| Prednisolone | 4 | |
|
| Solu-Medrol Infusion | 4 | |
|
| Sandimmune | 4 | |
|
| Advagraf | 3 | |
|
| Deltasone | 2 | |
|
| MS Phase 3 Study Fingolimod FREEDOMS II | 2 | |
|
| Zenapax | 2 | |
|
| Orencia | 2 | |
|
| Certican | 1 | |
|
| Simulect | 1 | |
|
| Wockhardt Methylprednisolone | 1 | |
|
| Lisinopril | 1 | |
|
| Kidney Transplant Phase 3 Belatacept BENEFIT | 1 | |
|
| CytoGam | 1 | |
|
| Medications | 1 | |
|
| Biopsy | 1 | |
Report created on February 12, 2012.